Sofiva Genomics Company Description

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally.

The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessment for early/late-onset preeclampsia, folate metabolism genetic testing, congenital infection screening,carrier scan, thalassemia genetic testing, spinal muscular atrophy genetic testing, and fragile X syndrome genetic testing.

It also provides baby genetic testing comprising sensorineural hearing loss genetic testing; congenital central hypoventilation syndrome genetic testing (CCHS); and congenital cytomegalovirus infection testing (CMV).

In addition, the company offers cancer screening services that include human papillomavirus screening (HPV); and hereditary cancer testing services.

Further, it develops precision medicine genetic testing; and offers testing services to patients and carrier with rare disorders.

Sofiva Genomics Co.,Ltd. was founded in 2012 and is based in Taipei, Taiwan.

Sofiva Genomics Co.,Ltd.

Country	Taiwan
Founded	2012
Industry	Diagnostics & Research
Sector	Healthcare
Employees	104
CEO	Chia-Cheng Hung

Contact Details

Address: No. 66-1, Chongqing S. Road Taipei, 100 Taiwan
Phone	886 2 2382 6615
Website	sofivagenomics.com.tw

Stock Details

Ticker Symbol	6615
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0006615008
SIC Code	8071

Key Executives

Name	Position
Dr. Chia-Cheng Hung	General Manager
Fu-Chien Chang	Finance Director and Chief Accounting Supervisor